DuPont Faces Analyst Price Target Cuts Amid Quiet Week for Company News

This past week, DuPont (NYSE: DD) was the focus of analyst revisions rather than corporate developments. Citigroup lowered its price target from $170 to $162 while reaffirming a “Buy” rating, and UBS followed suit by trimming its target from $178 to $172 while maintaining its positive stance.

These price target adjustments appear to be among the most material events impacting DuPont in the past seven days. Notably, they were published last week and reflect updated expectations regarding the company’s outlook. No new earnings reports, partnership announcements, regulatory filings, or other material corporate developments were disclosed during the same period.

Stock Price Movements

According to available summary data, DuPont’s stock declined approximately 0.95% over the week, moving from around $131.25 to $130.00, with a weekly high near $134.00 and a low near $129.18. This price action coincided with the analyst target cuts, though no media reported a direct causal link between them and the week’s trading range.

Context and Disclosures

Citigroup and UBS, in separate analyst updates, adjusted their price targets downward. Citigroup’s revision from $170 to $162 underscores a more cautious near-term view despite maintaining a bullish rating. Similarly, UBS kept its “Buy” outlook intact while reducing its target from $178 to $172.

The absence of fresh corporate developments—such as earnings releases, strategic announcements, or regulatory updates—suggests that these analyst actions were predominantly influenced by external or market-wide factors rather than specific news from DuPont.

Looking Ahead

Investors may want to await the company’s third-quarter 2026 earnings, scheduled for release on November 3, 2026, before expecting clearer directional cues. In the meantime, the recent analyst target revisions stand out as the primary development affecting the stock last week.

Verified stock note: DuPont’s live stock price was confirmed at $131.60, reflecting a 2.09% gain as of October 15, 2026.

Overall, this week’s activity underscores moderate investor caution in the absence of fresh catalyst-driven news, with analysts recalibrating expectations amid stable corporate fundamentals.